Response to study treatment. (A) Response table showing response parameters for the whole study and the MTD dose level (median follow-up, 14.2 months). (B) PFS for all patients. (C) PFS for the subset of patients that experienced a CR, CRu, or PR. CR, complete response; CRu, unconfirmed complete response; NE, not estimable; PR, partial response.